Publications by authors named "Nicholas Giacalone"

Claim this Profile
H
Head and Neck Cancer Clinical Research on ClinicalTrials.gov: An Opportunity for Radiation Oncologists.
Vinayak Muralidhar, Nicholas J Giacalone, Nastaran Milani, Jonathan D Schoenfeld, Roy B Tishler

Adv Radiat Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low percentage of metastases in deep brain and temporal lobe structures.
Ted K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, Albert W Lee, Vikram Soni

Neuro Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.
Nicholas J Giacalone, Nastaran Milani, Bhupendra Rawal, Paul J Catalano, Paul L Nguyen

Int J Radiat Oncol Biol Phys· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Nicholas J Giacalone, Muhammad M Qureshi, Kimberley S Mak, Diana Kirke, Sagar A Patel

Laryngoscope· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol 2017;71:952-60. Methodological Issues to Avoid Misinterpretation.
Nicholas J Giacalone, Andrzej Niemierko, William U Shipley, Jason A Efstathiou

Eur Urol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
Sagar A Patel, Muhammad M Qureshi, Kimberley S Mak, Debjani Sahni, Nicholas J Giacalone

Head Neck· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Nicholas J Giacalone, William U Shipley, Rebecca H Clayman, Andrzej Niemierko, Michael Drumm

Eur Urol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Immune Response to Vaccination on FDG-PET/CT.
Mark Mingos, Stephanie Howard, Nicholas Giacalone, David Kozono, Heather Jacene

Nucl Med Mol Imaging· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial.
Nicholas J Giacalone, Jing Wu, Ming-Hui Chen, Andrew Renshaw, Marian Loffredo

J Clin Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of M867, a selective caspase-3 inhibitor, in an orthotopic mouse model for non-small cell lung carcinoma.
Bo Li, Justin M Le Blanc, Yunguang Sun, Lifeng Yang, Nicholas G Zaorsky, Nicholas J Giacalone

Am J Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK.
Yunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, Chia-Lin Winchester, Kunal Dalal, Nicholas J Giacalone

Mol Cancer Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma.
Nicholas J Giacalone, Robert B Den, Rosana Eisenberg, Heidi Chen, Sandra J Olson

Future Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.
Yunguang Sun, Siyuan Zheng, Artour Torossian, Christina K Speirs, Stephen Schleicher, Nicholas J Giacalone

Int J Radiat Oncol Biol Phys· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro.
Wenyan Li, Bo Li, Nicholas J Giacalone, Artour Torossian, Yunguang Sun

J Thorac Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel bioluminescence orthotopic mouse model for advanced lung cancer.
Bo Li, Artour Torossian, Wenyan Li, Stephen Schleicher, Kathy Niu, Nicholas J Giacalone

Radiat Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
Luigi Moretti, Kenneth Niermann, Stephen Schleicher, Nicholas J Giacalone, Vinod Varki

Int J Radiat Oncol Biol Phys· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.
Kenneth J Niermann, Luigi Moretti, Nicholas J Giacalone, Yunguang Sun, Stephen M Schleicher

Radiat Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.
Yunguang Sun, Luigi Moretti, Nicholas J Giacalone, Stephen Schleicher, Christina K Speirs

J Thorac Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
Yunguang Sun, Nicholas J Giacalone, Bo Lu

J Thorac Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects.
Greg Noel, Quan Wang, Andrew Osterburg, Sandy Schwemberger, Laura James, Nicholas Giacalone

Shock· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis